Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 241

1.

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.

de Boissieu P, Dramé M, Raffi F, Cabie A, Poizot-Martin I, Cotte L, Garraffo R, Delobel P, Huleux T, Rey D, Bani-Sadr F; Dat’AIDS Study Group.

Medicine (Baltimore). 2016 Sep;95(37):e4890. doi: 10.1097/MD.0000000000004890.

2.

Prevalence of and factors associated with depression among people living with HIV in France.

Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group.

HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12438. [Epub ahead of print]

PMID:
27625202
3.

ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study).

Kheloufi F, Poizot-Martin I, Garraffo R, Tavenard A, Quaranta S, Renault A, Lavrut T, Bourlière M, Halfon P, Piroth L, Bellissant E, Lacarelle B, Molina JM, Solas C; ANRS HC, Group BS.

Antivir Ther. 2016 Sep 1. doi: 10.3851/IMP3074. [Epub ahead of print]

PMID:
27583701
4.

A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety.

Poizot-Martin I, Brégigeon S, Tamalet C, Bouabdallah R, Zaegel-Faucher O, Obry-Roguet V, Ivanova A, Cano CE, Solas C.

Case Rep Oncol Med. 2016;2016:8515218. doi: 10.1155/2016/8515218. Epub 2016 Jul 20.

5.

HEP-14 - Caractéristiques des patients en échec de traitement par combinaisons d'antiviraux à action directe (AAD) chez les patients co-infectés VIH/VHC.

Salmon D, Gilbert C, Rosenthal E, Miailhes P, Chas J, Lacombe K, Poizot-Martin I, Gervais A, Sogni P, Wittkop Pour la Cohorte L; ANRS CO13 HEPAVIH.

Med Mal Infect. 2016 Jun;46(4 Suppl 1):55. doi: 10.1016/S0399-077X(16)30391-2. French. No abstract available.

PMID:
27495529
6.

COL 3-04 - Abacavir/lamivudine/nevirapine comparée aux trithérapies classiques dans la cohorte Dat'AIDS : efficacité virologique similaire et meilleure tolérance à long terme.

de Boissieu P, Drame M, Raffi F, Cabié A, Poizot-Martin I, Cotte L, Delobel P, Huleux T, Rey D, Bani-Sadr F.

Med Mal Infect. 2016 Jun;46(4 Suppl 1):6. doi: 10.1016/S0399-077X(16)30269-4. French. No abstract available.

PMID:
27495405
7.

Hepatitis C treatment initiation in HIV-HCV coinfected patients.

Cotte L, Pugliese P, Valantin MA, Cuzin L, Billaud E, Duvivier C, Naqvi A, Cheret A, Rey D, Pradat P, Poizot-Martin I; Dat’AIDS study Group.

BMC Infect Dis. 2016 Jul 22;16:345. doi: 10.1186/s12879-016-1681-1.

8.

Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group.

Makinson A, Le Moing V, Reynes J, Ferry T, Lavole A, Poizot-Martin I, Pujol JL, Spano JP, Milleron B.

J Thorac Oncol. 2016 Oct;11(10):1644-52. doi: 10.1016/j.jtho.2016.06.026. Epub 2016 Jul 20. Review.

PMID:
27449803
9.

Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.

Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D.

AIDS Res Hum Retroviruses. 2016 Sep 7. [Epub ahead of print]

PMID:
27405442
10.

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.

Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, Bouchaud O, Lascoux-Combe C, Bani-Sadr F, Alric L, Goujard C, Vittecoq D, Billaud E, Aumaître H, Boué F, Valantin MA, Dabis F, Salmon D, Wittkop L.

Clin Infect Dis. 2016 Sep 15;63(6):763-70. doi: 10.1093/cid/ciw379. Epub 2016 Jun 17.

PMID:
27317796
11.

Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].

Michel L, Lions C, Winnock M, Lang JP, Loko MA, Rosenthal E, Marchou B, Valantin MA, Morlat P, Roux P, Sogni P, Spire B, Poizot-Martin I, Lacombe K, Lascoux-Combe C, Duvivier C, Neau D, Dabis F, Salmon-Ceron D, Carrieri MP; ANRS HEPAVIH CO13 study group.

HIV Med. 2016 May 17. doi: 10.1111/hiv.12382. [Epub ahead of print]

PMID:
27187027
12.

Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).

Marcellin F, Protopopescu C, Poizot-Martin I, Miailhes P, Esterle L, Wittkop L, Spire B, Bocquier A, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group.

Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1003-7. doi: 10.1097/MEG.0000000000000664.

PMID:
27177169
13.

Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.

Kheloufi F, Bellissant E, Cotte L, Poizot-Martin I, Quaranta S, Garraffo R, Barrail-Tran A, Renault A, Fournier I, Lacarelle B, Bourlière M, Molina JM, Solas C; ANRS HC27 BOCEPREVIH & HC26 TELAPREVIH Study Groups.

AIDS. 2016 Aug 24;30(13):2085-90. doi: 10.1097/QAD.0000000000001143.

PMID:
27149089
14.

From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).

Marcellin F, Fournier I, Carrieri MP, Poizot-Martin I, Cotte L; ANRS HC26 & ANRS HC27 Study Groups.

Eur J Gastroenterol Hepatol. 2016 Jun;28(6):733-4. doi: 10.1097/MEG.0000000000000612. No abstract available.

PMID:
27111390
15.

Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.

Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L; Dat'AIDS Study group.

HIV Med. 2016 May;17(5):380-4. doi: 10.1111/hiv.12306. Epub 2015 Aug 26.

PMID:
27093565
16.

Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.

Poizot-Martin I, Bellissant E, Garraffo R, Colson P, Piroth L, Solas C, Renault A, Bourlière M, Halfon P, Ghosn J, Alric L, Naqvi A, Carrieri P, Molina JM; ANRS HC27 BOCEPREVIH Study Group.

HIV Clin Trials. 2016 Mar;17(2):63-71. doi: 10.1080/15284336.2015.1135553. Epub 2016 Feb 11.

PMID:
27077673
17.

Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.

Hentzien M, Dramé M, Allavena C, Jacomet C, Valantin MA, Cabié A, Cuzin L, Rey D, Pugliese P, Bani-Sadr F; Dat'AIDS Study Group.

J Nutr Health Aging. 2016 Apr;20(4):408-14. doi: 10.1007/s12603-015-0608-7.

PMID:
26999241
18.

Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.

Makinson A, Eymard-Duvernay S, Raffi F, Abgrall S, Bommart S, Zucman D, Valour F, Cheret A, Poizot-Martin I, Duvivier C, Mauboussin JM, Bonnet F, Tattevin P, Reynes J, Le Moing V; ANRS EP48 HIV CHEST study Team.

AIDS. 2016 Feb 20;30(4):573-82. doi: 10.1097/QAD.0000000000000943.

PMID:
26829006
19.

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.

Allavena C, Katlama C, Cotte L, Roger PM, Delobel P, Cheret A, Duvivier C, Poizot-Martin I, Hoen B, Cabie A, Cheret A, Lahoulou R, Raffi F, Pugliese P; Dat’AIDS Study group.

Infect Dis (Lond). 2016;48(5):392-8. doi: 10.3109/23744235.2015.1133927. Epub 2016 Jan 13.

PMID:
26757613
20.

Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.

Suzan-Monti M, Lorente N, Demoulin B, Marcellin F, Préau M, Dray-Spira R, Lert F, Spire B; ANRS-VESPA2 Study Group.

J Int AIDS Soc. 2016 Jan 8;19(1):20095. doi: 10.7448/IAS.19.1.20095. eCollection 2016.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk